跳至主要内容
临床试验/ITMCTR2200005962
ITMCTR2200005962尚未招募未知

Efficacy and Safety of Qingfei Paidu granule for treatment of asymptomatic / mild / common COVID-19 infections in children

Shanghai Children's Medical Center0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
3 至 18(—)
性别
All

入选标准

  • 1) Aged 3 ~ 18 years old;
  • 2) Coincidence the diagnostic criteria of the diagnosis and treatment plan for pneumonia infected by COVID-19 (trial version 9);
  • 3) mild/ common/ asymptomatic COVID-19 infection;
  • 4) The informed consent process complies with the regulations, and the legal guardian and/ or the test child (= 8 years old) jointly sign the ICF.

排除标准

  • 1) Be are allergic to the test drug and intolerant to the drug;
  • 2) cant ensure medication compliance during treatment and are difficult to give drugs by oral administration;
  • 3) With basic respiratory diseases, malignant tumors, mental diseases and other malignant diseases of the system.

研究者

发起方
Shanghai Children's Medical Center

相似试验